Mycobacterium tuberculosis microbiologic and clinical treatment outcomes in a randomized trial of immediate versus CD4+-initiated antiretroviral therapy in HIV-infected adults with a high CD4+ cell count

Clinical Infectious Diseases

Volumn 51, Issue 3, 2010, Pages 359-362

  Chamie, Gabriel ^a,b   Charlebois, Edwin D ^b   Srikantiah, Padmini ^a   Walusimbi Nanteza, Maria ^d   Mugerwa, Roy D ^d   Mayanja, Harriet ^d   Okwera, Alphonse ^e   Whalen, Christopher C ^c   Havlir, Diane V ^a  

^a SAN FRANCISCO GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF GEORGIA   (United States)

^d MAKERERE UNIVERSITY MEDICAL SCHOOL   (Uganda)

^e MULAGO HOSPITAL   (Uganda)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ETHAMBUTOL; ISONIAZID; LAMIVUDINE; PYRAZINAMIDE; RIFAMPICIN; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DRUG TREATMENT FAILURE; DYSPNEA; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RASH; RECURRENT DISEASE; SPUTUM SMEAR; THORAX RADIOGRAPHY; UPPER RESPIRATORY TRACT INFECTION; CD4 LYMPHOCYTE COUNT; COMPLICATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV INFECTIONS; IMMUNOLOGY; ISOLATION AND PURIFICATION; LUNG; MICROBIOLOGY; PATHOLOGY; PROCEDURES; SPUTUM; TREATMENT OUTCOME; TUBERCULOSIS; UGANDA;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANTITUBERCULAR AGENTS; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HUMANS; LUNG; MALE; MYCOBACTERIUM TUBERCULOSIS; PROSPECTIVE STUDIES; RADIOGRAPHY, THORACIC; SPUTUM; TREATMENT OUTCOME; TUBERCULOSIS; UGANDA;

EID: 77954697537     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/654799     Document Type: Article

References (14)

1. World Health Organization (WHO). HIV/AIDS. 30 November 2009. Rapid advice: antiretroviral therapy for HIV infection in adults and adolescents. WHO Web site. http://www.who.int/hiv/pub/arv/advice/ en/. Accessed 8 February 2010.
2. Revised international definitions in tuberculosis control. Int J Tuberc Lung Dis 2001; 5(3):213-215.
3. Narita M, Ashkin D, Hollender ES, Pitchenik AE. Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. Am J Respir Crit Care Med 1998; 158(1):157-161.
4. American Thoracic Society; Centers for Disease Control and Prevention. Diagnostic standards and classification of tuberculosis in adults and children. Am J Resp Crit Care Med 2000; 161(4 Pt 1):1376-1395.
5. Boom WH, Canaday DH, Fulton SA, Gehring AJ, Rojas RE, Torres M. Human immunity to M. tuberculosis: T cell subsets and antigen processing. Tuberculosis 2003; 83(1-3):98-106.
6. Murray J, Sonnenberg P, Shearer SC, Godfrey-Faussett P. Human immunodeficiency virus and the outcome of treatment for new and recurrent pulmonary tuberculosis in African patients. Am J Respir Crit Care Med 1999; 159(3):733-740.
7. Perriëns JH, St Louis ME, Mukadi YB, et al. Pulmonary tuberculosis in HIV-infected patients in Zaire-a controlled trial of treatment for either 6 or 12 months. New Engl J Med 1995; 332(12):779-784.
8. Nahid P, Gonzalez LC, Rudoy I, et al. Treatment outcomes of patients with HIV and tuberculosis. Am J Respir Crit Care Med 2007; 175(11): 1199-1206.
9. Gulick RM, Ribaudo HJ, Shikuma CM, et al. Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infection. New Engl J Med 2004; 350(18):1850-1861.
10. Lawn SD, Myer L, Edwards D, Bekker LG, Wood R. Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa. AIDS 2009; 23(13):1717-1725.
11. Kitahata MM, Gange SJ, Abraham AG, et al. Effect of early versus deferred antiretroviral therapy for HIV on survival. New Engl J Med 2009; 360(18):1815-1826.
12. Mugusi F, Villamor E, Urassa W, Saathoff E, Bosch RJ, Fawzi WW. HIV co-infection, CD4 cell counts and clinical correlates of bacillary density in pulmonary tuberculosis. Int J Tuberc Lung Dis 2006; 10(6): 663-669.
13. Vidal R, Martin-Casabona N, Juan A, Falgueras T, Miravitlles M. Incidence and significance of acid-fast bacilli in sputum smears at the end of antituberculous treatment. Chest 1996; 109(6):1562-1565.
14. Palaci M, Dietze R, Hadad DJ, et al. Cavitary disease and quantitative sputum bacillary load in cases of pulmonary tuberculosis. J Clin Microbiol 2007; 45(12):4064-4066.